$TRXDW

2020 Q4 Form 10-Q Financial Statement

#000143774920022801 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $1.107M $814.0K $2.024M
YoY Change 61.14% -59.78% -62.67%
Cost Of Revenue $593.0K $1.423M $3.446M
YoY Change -94.55% -58.71% -18.9%
Gross Profit $514.0K -$609.0K -$1.422M
YoY Change -105.04% -57.17% -221.23%
Gross Profit Margin 46.43% -74.82% -70.26%
Selling, General & Admin $6.484M $6.598M $12.79M
YoY Change -30.93% -48.42% 34.57%
% of Gross Profit 1261.48%
Research & Development $3.750M $4.673M $5.884M
YoY Change -19.08% -20.58% 21.62%
% of Gross Profit 729.57%
Depreciation & Amortization $3.720M $3.634M $3.070M
YoY Change -70.16% 18.37% -6.12%
% of Gross Profit 723.74%
Operating Expenses $14.23M $14.55M $96.43M
YoY Change -14.82% -84.91% 572.29%
Operating Profit -$13.72M -$15.16M -$97.85M
YoY Change -49.01% -84.5% 723.58%
Interest Expense -$148.0K $0.00 $1.230M
YoY Change -92.49% -100.0% 79.56%
% of Operating Profit
Other Income/Expense, Net -$65.00K $82.00K -$992.0K
YoY Change 103.13% -108.27% -89.11%
Pretax Income -$13.92M -$15.08M -$98.84M
YoY Change -2.7% -84.74% 370.96%
Income Tax -$130.0K $2.000K -$1.070M
% Of Pretax Income
Net Earnings -$13.79M -$15.08M -$97.77M
YoY Change 0.43% -84.57% 383.87%
Net Earnings / Revenue -1245.8% -1852.83% -4830.58%
Basic Earnings Per Share -$0.15 -$5.55
Diluted Earnings Per Share -$132.6K -$0.15 -$5.55
COMMON SHARES
Basic Shares Outstanding 99.91M 97.54M 17.63M
Diluted Shares Outstanding 97.54M 17.74M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.36M $19.96M $22.10M
YoY Change 70.48% -9.67% -72.85%
Cash & Equivalents $16.36M $20.00M $22.11M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $2.966M $5.780M $8.762M
YoY Change -58.13% -34.03% -3.06%
Inventory $10.03M $10.86M $13.66M
Prepaid Expenses $3.535M $2.186M
Receivables $1.115M $903.0K $2.352M
Other Receivables $2.870M $0.00 $21.00K
Total Short-Term Assets $34.01M $37.50M $46.90M
YoY Change 21.67% -20.03% -55.93%
LONG-TERM ASSETS
Property, Plant & Equipment $10.34M $8.702M $5.428M
YoY Change 119.76% 60.32% -18.49%
Goodwill $0.00
YoY Change -100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $186.0K $1.836M $2.584M
YoY Change -92.53% -28.95% 1053.57%
Total Long-Term Assets $44.25M $42.64M $50.74M
YoY Change -5.51% -15.95% -58.12%
TOTAL ASSETS
Total Short-Term Assets $34.01M $37.50M $46.90M
Total Long-Term Assets $44.25M $42.64M $50.74M
Total Assets $78.26M $80.14M $97.63M
YoY Change 4.65% -17.91% -57.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.965M $2.973M $3.403M
YoY Change -45.1% -12.64% 22.19%
Accrued Expenses $5.615M $7.492M $8.094M
YoY Change -34.35% -7.44% 8.91%
Deferred Revenue $789.0K $818.0K $884.0K
YoY Change -3.55% -7.47% -30.39%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.228M $279.0K
YoY Change
Total Short-Term Liabilities $10.28M $11.56M $12.45M
YoY Change -21.04% -7.15% 3.4%
LONG-TERM LIABILITIES
Long-Term Debt $1.587M $2.536M $15.30M
YoY Change -83.42% -19.9%
Other Long-Term Liabilities $628.0K $973.0K $1.590M
YoY Change -55.24% -38.81% -94.04%
Total Long-Term Liabilities $2.215M $3.509M $1.590M
YoY Change 57.88% 120.69% -96.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.28M $11.56M $12.45M
Total Long-Term Liabilities $2.215M $3.509M $1.590M
Total Liabilities $16.69M $17.98M $33.87M
YoY Change -13.28% -46.93% -46.66%
SHAREHOLDERS EQUITY
Retained Earnings -$722.9M -$709.1M -$649.9M
YoY Change 8.94% 9.11% 29.21%
Common Stock $781.5M $770.5M $716.7M
YoY Change 8.47% 7.51% 7.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.57M $62.17M $63.77M
YoY Change
Total Liabilities & Shareholders Equity $78.26M $80.14M $97.63M
YoY Change 4.65% -17.91% -57.1%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$13.79M -$15.08M -$97.77M
YoY Change 0.43% -84.57% 383.87%
Depreciation, Depletion And Amortization $3.720M $3.634M $3.070M
YoY Change -70.16% 18.37% -6.12%
Cash From Operating Activities -$12.77M -$8.774M -$19.58M
YoY Change -82.63% -55.19% 19.03%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $200.0K
YoY Change -100.0% -100.0% 53.85%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $10.00M
YoY Change -100.0% -100.0% -125.24%
Cash From Investing Activities $0.00 $0.00 $9.800M
YoY Change -100.0% -100.0% -124.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.936M 13.65M 8.730M
YoY Change -259.32% 56.35% 5720.0%
NET CHANGE
Cash From Operating Activities -12.77M -8.774M -19.58M
Cash From Investing Activities 0.000 0.000 9.800M
Cash From Financing Activities 8.936M 13.65M 8.730M
Net Change In Cash -3.829M 4.875M -1.050M
YoY Change -66.55% -564.29% -98.13%
FREE CASH FLOW
Cash From Operating Activities -$12.77M -$8.774M -$19.58M
Capital Expenditures $0.00 $0.00 $200.0K
Free Cash Flow -$12.77M -$8.774M -$19.78M
YoY Change -82.52% -55.64% 19.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
99910279
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99879029
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99879029
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20691301
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20691301
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1600000 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1700000 USD
trxc Period Of Service Sale Arrangement
PeriodOfServiceSaleArrangement
P5Y
trxc Period Of Service Sale Arrangement At Stated Service Price
PeriodOfServiceSaleArrangementAtStatedServicePrice
P4Y
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
814000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2024000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2068000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7844000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1423000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3446000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4573000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9849000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
-609000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
-1422000 USD
us-gaap Gross Profit
GrossProfit
-2505000 USD
us-gaap Gross Profit
GrossProfit
-2005000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4673000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5884000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12867000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17834000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3136000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6883000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10291000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22425000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3462000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5908000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10426000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14959000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2780000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2558000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7964000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7754000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
502000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-11647000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1770000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-9689000 USD
CY2020Q3 trxc Restructuring And Other Charges
RestructuringAndOtherCharges
0 USD
CY2019Q3 trxc Restructuring And Other Charges
RestructuringAndOtherCharges
0 USD
trxc Restructuring And Other Charges
RestructuringAndOtherCharges
858000 USD
trxc Restructuring And Other Charges
RestructuringAndOtherCharges
0 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
78969000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
78969000 USD
CY2020Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2019Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
7912000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
7912000 USD
CY2020Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
CY2019Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-97000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-40000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
14553000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
96427000 USD
us-gaap Operating Expenses
OperatingExpenses
44176000 USD
us-gaap Operating Expenses
OperatingExpenses
140266000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15162000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-97849000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-46681000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-142271000 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-63000 USD
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-614000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
206000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3036000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
63000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
34000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
559000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
-0 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
1230000 USD
us-gaap Interest Expense
InterestExpense
-0 USD
us-gaap Interest Expense
InterestExpense
3407000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-439000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-54000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-935000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
82000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-992000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-226000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-747000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15080000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-98841000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46907000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143018000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1070000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3670000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1386000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2549000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15082000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-97771000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45521000 USD
us-gaap Net Income Loss
NetIncomeLoss
-140469000 USD
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
412000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
CY2020Q3 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
-0 USD
CY2019Q3 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
-0 USD
us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
299000 USD
us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
-0 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15082000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-97771000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46232000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-140469000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15082000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-97771000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45521000 USD
us-gaap Net Income Loss
NetIncomeLoss
-140469000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2101000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2191000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4379000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12981000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-101441000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43330000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-144848000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.26
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.34
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97538000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17629000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59737000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17015000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97538000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17741000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59737000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17208000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19964000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9598000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
903000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
620000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10856000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
10653000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5780000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7084000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
37503000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
27955000 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1154000 USD
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
969000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2536000 USD
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
6769000 USD
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7594000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8702000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4706000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
41000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1836000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2489000 USD
CY2020Q3 us-gaap Assets
Assets
80144000 USD
CY2019Q4 us-gaap Assets
Assets
74779000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2973000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3579000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7492000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8553000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
818000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
818000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
279000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
73000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11562000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13023000 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
27000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2780000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1011000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q3 trxc Warrant Liability
WarrantLiability
124000 USD
CY2019Q4 trxc Warrant Liability
WarrantLiability
2388000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1392000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
973000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1403000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
17975000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
19244000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
770368000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
720484000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-709120000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-663600000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
821000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1370000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
62169000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55535000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80144000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74779000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55535000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1923000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11212000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2020Q1 trxc Stock Issued During Period Value Exchange Of Shares For Warrants
StockIssuedDuringPeriodValueExchangeOfSharesForWarrants
2470000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
33000 USD
CY2020Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
-0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-872000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-16598000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
67162000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1933000 USD
CY2020Q2 trxc Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
3340000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
962000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-13840000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
59557000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1944000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13649000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2101000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15082000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
62169000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
168521000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2981000 USD
CY2019Q1 trxc Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
236000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
499000 USD
CY2019Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
-0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1949000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-22525000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
146766000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3355000 USD
CY2019Q2 trxc Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
297000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1240000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-20171000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
131487000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3391000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23725000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6600000 USD
CY2019Q3 trxc Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
6000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3670000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-97771000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
63768000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45521000 USD
us-gaap Net Income Loss
NetIncomeLoss
-140469000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-97000 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
86881000 USD
us-gaap Depreciation
Depreciation
2015000 USD
us-gaap Depreciation
Depreciation
1651000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7964000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7754000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1437000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
328000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33910000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9727000 USD
trxc Business Combination Interest Expense On Deferred Consideration
BusinessCombinationInterestExpenseOnDeferredConsideration
0 USD
trxc Business Combination Interest Expense On Deferred Consideration
BusinessCombinationInterestExpenseOnDeferredConsideration
762000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1386000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
252000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4313000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59116000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
-0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
206000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3036000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1770000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-9689000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2549000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1630000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
761000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-0 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4410000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14141000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2233000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2313000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-706000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-914000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1191000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1439000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-56000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-867000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-376000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1613000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
12883000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
65000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
392000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51725000 USD
trxc Proceeds From Issuance Of Equity Net
ProceedsFromIssuanceOfEquityNet
13525000 USD
trxc Proceeds From Issuance Of Equity Net
ProceedsFromIssuanceOfEquityNet
0 USD
trxc Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
24861000 USD
trxc Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
23725000 USD
trxc Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts
2815000 USD
trxc Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts
-30000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
33000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
499000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
74000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
-0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3340000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
539000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44434000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8735000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-191000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10551000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1153000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10567000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21651000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21118000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22804000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
2073000 USD
trxc Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
5839000 USD
trxc Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
478000 USD
us-gaap Stock Issued1
StockIssued1
2470000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
trxc Transfer Of In Process Research And Development To Intellectual Property
TransferOfInProcessResearchAndDevelopmentToIntellectualProperty
2425000 USD
trxc Transfer Of In Process Research And Development To Intellectual Property
TransferOfInProcessResearchAndDevelopmentToIntellectualProperty
0 USD
trxc Issuance Of Common Stock Value For Acquisitions
IssuanceOfCommonStockValueForAcquisitions
0 USD
trxc Issuance Of Common Stock Value For Acquisitions
IssuanceOfCommonStockValueForAcquisitions
6600000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
79000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
261900000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20200000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-709100000 USD
CY2020Q3 trxc Working Capital
WorkingCapital
26100000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20000000.0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include identifiable intangible assets and goodwill, contingent consideration, warrant liabilities, stock compensation expense, revenue recognition, accounts receivable reserves, excess and obsolete inventory reserves, inventory classification between current and non-current, and deferred tax asset valuation allowances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The COVID-<em style="font: inherit;">19</em> pandemic has caused significant social and economic restrictions that have been imposed in the United States and abroad, which has resulted in significant volatility in the global economy and led to reduced economic activity. In the preparation of these financial statements and related disclosures, the Company has assessed the impact that COVID-<em style="font: inherit;">19</em> has had on its estimates, assumptions, forecasts, and accounting policies. The Company continues to monitor closely the COVID-<em style="font: inherit;">19</em> pandemic impact on its estimates, assumptions and forecasts used in the preparation of its financial statements. As the COVID-<em style="font: inherit;">19</em> situation is unprecedented and ever evolving, future events and effects related to COVID-<em style="font: inherit;">19</em> cannot be determined with precision, and actual results could significantly differ from estimates or forecasts.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Concentrations and Credit Risk</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents, including amounts held in money market accounts. The Company places cash deposits with a federally insured financial institution. The Company maintains its cash at banks and financial institutions it considers to be of high credit quality; however, the Company’s domestic cash deposits <em style="font: inherit;"> may </em>at times exceed the Federal Deposit Insurance Corporation’s insured limit. Balances in excess of federally insured limitations <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be insured. The Company has <em style="font: inherit;">not</em> experienced losses on these accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company’s accounts receivable are derived from sales to customers located throughout the world. The Company evaluates its customers’ financial condition and, generally, requires <em style="font: inherit;">no</em> collateral from its customers. The Company provides reserves for potential credit losses and recorded a bad debt charge totaling $1.6 million during the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2019 (</em><em style="font: inherit;"><span style="-sec-ix-hidden:c66395140"><span style="-sec-ix-hidden:c66395141">none</span></span></em> during the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2020). </em>The Company had seven customers who constituted 69% of the Company’s net accounts receivable as of <em style="font: inherit;"> September 30, 2020. </em>The Company had <span style="-sec-ix-hidden:c66394925">eight</span> customers who constituted 85% of the Company’s net accounts receivable as of <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2019.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company had nine customers who accounted for 57% of revenue for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2020 </em>and <span style="-sec-ix-hidden:c66394933">five</span> customers who accounted for 83% of revenue for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2019. </em>The Company had <span style="-sec-ix-hidden:c66394936">nine</span> customers who accounted for 58% of revenue for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2020 </em>and five customers who accounted for 83% of revenue for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2019.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b> </b></p>
CY2019Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1600000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1000000.0 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1200000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1700000 USD
CY2019Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
79000000.0 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
814000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2024000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2068000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7844000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
200000 USD
CY2019Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
0 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
400000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
0 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3000000.0 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3700000 USD
CY2020Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
100000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
200000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1500000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3000000.0 USD
CY2020Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2019Q3 us-gaap Inventory Write Down
InventoryWriteDown
800000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3400000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5800000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9700000 USD
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1871289
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
19964000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1154000 USD
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21118000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2780000 USD
CY2020Q3 trxc Warrant Liability
WarrantLiability
124000 USD
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2904000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9598000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
969000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
10567000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1084000 USD
CY2019Q4 trxc Warrant Liability
WarrantLiability
2388000 USD
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
3472000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
500000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1800000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-11600000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-9700000 USD
CY2017Q2 trxc Number Of Units Sold
NumberOfUnitsSold
24900000
CY2017Q2 trxc Number Of Shares In Each Unit
NumberOfSharesInEachUnit
0.077
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10619000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9737000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7006000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8510000 USD
CY2020Q3 trxc Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
17625000 USD
CY2019Q4 trxc Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
18247000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10856000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
10653000 USD
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
6769000 USD
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7594000 USD
CY2020Q3 trxc Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
17625000 USD
CY2019Q4 trxc Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
18247000 USD
CY2019 us-gaap Other Restructuring Costs
OtherRestructuringCosts
7400000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
69238000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
46970000 USD
CY2020Q3 trxc Finite Lived Intangible Assets Foreign Currency Translation Impact
FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact
1871000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24139000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66813000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37030000 USD
CY2019Q4 trxc Finite Lived Intangible Assets Foreign Currency Translation Impact
FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact
-1187000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28596000 USD
CY2020Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
400000 USD
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
46498909
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.011 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.030 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.018 pure
CY2020Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0.00 USD
CY2019Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1070000.00 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1390000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2550000 USD
CY2020Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0.00 USD
CY2019Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20000.00 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
40000.00 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
50000.00 USD
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
8800000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
882000 USD
us-gaap Restructuring Charges
RestructuringCharges
858000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
1156000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
584000 USD
CY2019Q3 trxc Earnings Per Share Potentially Dilutive Securities Warrants
EarningsPerSharePotentiallyDilutiveSecuritiesWarrants
112000
trxc Earnings Per Share Potentially Dilutive Securities Warrants
EarningsPerSharePotentiallyDilutiveSecuritiesWarrants
193000
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-600000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3000000.0 USD

Files In Submission

Name View Source Status
0001437749-20-022801-index-headers.html Edgar Link pending
0001437749-20-022801-index.html Edgar Link pending
0001437749-20-022801.txt Edgar Link pending
0001437749-20-022801-xbrl.zip Edgar Link pending
ex_210839.htm Edgar Link pending
ex_210840.htm Edgar Link pending
ex_210841.htm Edgar Link pending
ex_210925.htm Edgar Link pending
ex_210926.htm Edgar Link pending
ex_210927.htm Edgar Link pending
ex_210928.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
transe20200930_10q.htm Edgar Link pending
transe20200930_10q_htm.xml Edgar Link completed
trxc-20200930.xsd Edgar Link pending
trxc-20200930_cal.xml Edgar Link unprocessable
trxc-20200930_def.xml Edgar Link unprocessable
trxc-20200930_lab.xml Edgar Link unprocessable
trxc-20200930_pre.xml Edgar Link unprocessable